New research suggests that bacteriophage therapy could counteract the risk of secondary bacterial infections, which affect some patients with weakened immune systems after being infected with the SARS-CoV-2 coronavirus.
A novel application of bacteriophage therapy has saved the life of a man who contracted a multi-drug resistant bacterial infection. Phage therapy offers a promising new take on the fight against antibacterial resistance.
